Talking Medicines builds a world class team
November 9, 2020

Hot off of the press on raising £1.1M Talking Medicines are building out a world class product and tech team to realise its mission of creating the world’s first social intelligence company for the pharmaceutical industry.  In line with plans to scale up its AI-based data technology platform for measuring patient sentiment, the size of the team will double.  COO Elizabeth Fairley commented: “We are keen to attract talented NLP data scientists and a world class product team who are working at at the leading edge of their profession, and who want to join us in our fast and ambitious journey to create a product roadmap that will change the way patient intelligence can be accessed by pharmaceutical companies.”

Recruitment has been boosted with the support of Fabrice Retkowsky, the former CTO of social intelligence company Brandwatch.  Fabrice has been working with Talking Medicines as a consultant since September & has been instrumental in creating a hiring plan that will attract top global talent.  With his experience of developing Brandwatch into a global technology leader he is well placed to advise the team at Talking Medicines.

Talking Medicines have an HQ in Glasgow, and an office base in London. As the company scales globally it is envisaged that the team will be based globally. During Covid-19 the team have all worked remotely and this has been a big success for the Company.   New employees will be attracted to the opportunity to make a difference to both patient outcomes along with creating a world class product.  Personal growth matters and employees are given plenty of opportunities to learn new technologies, practices and techniques with room to grow. Talking Medicines embrace diversity and equal opportunity and are committed to building a team that represents a variety of backgrounds and perspectives.

Open roles include:
https://talkingmedicines.com/wp-content/uploads/Talking-Medicines-NPL-Expert.pdf

https://talkingmedicines.com/wp-content/uploads/Talking-Medicines-Head-of-Engineering.pdf

https://talkingmedicines.com/wp-content/uploads/Talking-Medicines-Backend-Developer.pdf

https://talkingmedicines.com/wp-content/uploads/Talking-Medicines-Frontend-Developer.pdf

https://talkingmedicines.com/wp-content/uploads/Talking-Medicines-Data-Science-Engineer.pdf

Full details are found on  https://talkingmedicines.com/careers/

Recent Blogs

Is the pharma industry ready to listen directly to patients?

Is the pharma industry ready to listen directly to patients?

COO Elizabeth Fairley was recently interviewed by publisher Drug Discovery World on whether the pharmaceutical industry is ready to listen directly to patients? Elizabeth commented that "There has been a growing realisation that pharmaceutical companies must change if...

Pfizer and BioNTech gain approval on new COVID-19 vaccine

Pfizer and BioNTech gain approval on new COVID-19 vaccine

This long-awaited moment has finally arrived! This morning, Pfizer and BioNTech’s vaccine has been approved for use in the UK as early as next week. It is the fastest vaccine ever to be developed, taking only 10 months to convert the concept into reality, a process...

Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday

Protecting Your Medical Data with Elizabeth Fairley and Ellie Halliday

DIGIT spoke with Elizabeth Fairley and Ellie Halliday of Talking Medicines about keeping your medical data safe in a Covid world. Medical data is among the most sensitive information a company can gather, store or track, and the coronavirus pandemic has heightened...

COVID-19 Vaccine: A fresh start

COVID-19 Vaccine: A fresh start

There is no doubt that 2020 has been a long, hard year. With the endless threat of new measures and long lockdowns, it is safe to say we could do with some good news. Finally, we have a glimmer of hope. First, Pfizer (Pharmaceutical company) announced the interim...